| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.064 | 0.2 |